Ohio panel reverses course on anxiety, autism as medical marijuana conditions

Be at the forefront of the latest cannabis scientific research. Submit a research abstract to present by Dec. 16, or register to attend the The Emerald Conference by MJBizScience, March 1-3 in San Diego.


Ohio’s fledgling medical marijuana market was dealt a blow when an expert panel rescinded its recommendation to approve anxiety and autism as qualifying conditions.

In neighboring Pennsylvania, adding anxiety to the MMJ list of conditions has resulted in a boom in patients and sales.

The Ohio medical board committee reversed its position after four of six experts testified against adding the two conditions, according to The Columbus Dispatch.

The experts testified that such approval was premature based on current evidence, according to the newspaper.

Earlier this summer, the panel rejected depression, insomnia and opioid addiction as qualifying conditions.

The full state medical board is likely to vote on the panel’s recommendation at its Sept. 11 meeting.